Chang Linda C, Haggstrom Anita N, Drolet Beth A, Baselga Eulalia, Chamlin Sarah L, Garzon Maria C, Horii Kimberly A, Lucky Anne W, Mancini Anthony J, Metry Denise W, Nopper Amy J, Frieden Ilona J
Department of Dermatology, University of California, San Francisco, California, USA.
Pediatrics. 2008 Aug;122(2):360-7. doi: 10.1542/peds.2007-2767.
Infantile hemangiomas often are inapparent at birth and have a period of rapid growth during early infancy followed by gradual involution. More precise information on growth could help predict short-term outcomes and make decisions about when referral or intervention, if needed, should be initiated. The objective of this study was to describe growth characteristics of infantile hemangioma and compare growth with infantile hemangioma referral patterns.
A prospective cohort study involving 7 tertiary care pediatric dermatology practices was conducted. Growth data were available for a subset of 526 infantile hemangiomas in 433 patients from a cohort study of 1096 children. Inclusion criteria were age younger than 18 months at time of enrollment and presence of at least 1 infantile hemangioma. Growth stage and rate were compared with clinical characteristics and timing of referrals.
Eighty percent of hemangioma size was reached during the early proliferative stage at a mean age of 3 months. Differences in growth between hemangioma subtypes included that deep hemangiomas tend to grow later and longer than superficial hemangiomas and that segmental hemangiomas tended to exhibit more continued growth after 3 months of age. The mean age of first visit was 5 months. Factors that predicted need for follow-up included ongoing proliferation, larger size, deep component, and segmental and indeterminate morphologic subtypes.
Most infantile hemangioma growth occurs before 5 months, yet 5 months was also the mean age at first visit to a specialist. Recognition of growth characteristics and factors that predict the need for follow-up could help aid in clinical decision-making. The first few weeks to months of life are a critical time in hemangioma growth. Infants with hemangiomas need close observation during this period, and those who need specialty care should be referred and seen as early as possible within this critical growth period.
婴儿血管瘤在出生时通常并不明显,在婴儿早期有一个快速生长阶段,随后逐渐消退。关于生长的更精确信息有助于预测短期预后,并决定何时(如有必要)进行转诊或干预。本研究的目的是描述婴儿血管瘤的生长特征,并将其生长情况与婴儿血管瘤的转诊模式进行比较。
开展了一项涉及7家三级医疗儿科皮肤科诊所的前瞻性队列研究。在一项对1096名儿童的队列研究中,有433名患者的526个婴儿血管瘤的生长数据可供分析。纳入标准为入组时年龄小于18个月且至少有1个婴儿血管瘤。将生长阶段和速率与临床特征及转诊时间进行比较。
80%的血管瘤大小在早期增殖阶段达到,平均年龄为3个月。血管瘤亚型之间的生长差异包括:深部血管瘤往往比浅表血管瘤生长得更晚且持续时间更长,节段性血管瘤在3个月龄后往往表现出更多的持续生长。首次就诊的平均年龄为5个月。预测需要随访的因素包括持续增殖、更大的尺寸、深部成分以及节段性和不确定形态学亚型。
大多数婴儿血管瘤的生长发生在5个月之前,但5个月也是首次就诊于专科医生的平均年龄。认识生长特征和预测随访需求的因素有助于临床决策。生命的最初几周至几个月是血管瘤生长的关键时期。在此期间,患有血管瘤的婴儿需要密切观察,那些需要专科护理的婴儿应在这个关键生长阶段尽早转诊并就诊。